Preclinical Investigation of Inhibition of the DNA Damage Response as a Targetted Therapy in Myeloproliferative Neoplasms Shows Synergism of ATR Inhibitors with Standard-of-Care Treatment

Edwin Chen; A Ślusarczyk; HE Bryant; I Hitchcock; M Zeidler; A Chantry; S Thomas

Preclinical Investigation of Inhibition of the DNA Damage Response as a Targetted Therapy in Myeloproliferative Neoplasms Shows Synergism of ATR Inhibitors with Standard-of-Care Treatment

Edwin Chen
, A Ślusarczyk
, HE Bryant
, I Hitchcock
, M Zeidler
, A Chantry
, S Thomas

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	17
Journal	Medical Sciences Forum
Volume	3
Publication status	Published - 2021

Access to Document

msf-03-00017.pdfFinal published version, 2.21 MB

Cite this

@article{1e357bb9635041a48b661e375de81ce0,

title = "Preclinical Investigation of Inhibition of the DNA Damage Response as a Targetted Therapy in Myeloproliferative Neoplasms Shows Synergism of ATR Inhibitors with Standard-of-Care Treatment",

author = "Edwin Chen and A {\'S}lusarczyk and HE Bryant and I Hitchcock and M Zeidler and A Chantry and S Thomas",

year = "2021",

language = "English",

volume = "3",

pages = "17",

journal = "Medical Sciences Forum",

publisher = "MDPI",

}

TY - JOUR

T1 - Preclinical Investigation of Inhibition of the DNA Damage Response as a Targetted Therapy in Myeloproliferative Neoplasms Shows Synergism of ATR Inhibitors with Standard-of-Care Treatment

AU - Chen, Edwin

AU - Ślusarczyk, A

AU - Bryant, HE

AU - Hitchcock, I

AU - Zeidler, M

AU - Chantry, A

AU - Thomas, S

PY - 2021

Y1 - 2021

M3 - Article

VL - 3

SP - 17

JO - Medical Sciences Forum

JF - Medical Sciences Forum

ER -